Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$281K Sell
7,933
-2,432
-23% -$99K ﹤0.01% 3835
2025
Q4
$421K Sell
10,365
-1,905
-16% -$82.9K ﹤0.01% 3651
2025
Q3
$577K Sell
12,270
-17,686
-59% -$917K ﹤0.01% 3505
2025
Q2
$1.56M Sell
29,956
-16,672
-36% -$915K ﹤0.01% 2857
2025
Q1
$2.82M Buy
46,628
+1,641
+4% +$106K ﹤0.01% 2396
2024
Q4
$3.08M Buy
44,987
+5,337
+13% +$372K ﹤0.01% 2437
2024
Q3
$2.85M Buy
39,650
+16,453
+71% +$1.16M ﹤0.01% 2359
2024
Q2
$1.61M Buy
23,197
+2,649
+13% +$193K ﹤0.01% 2532
2024
Q1
$1.65M Sell
20,548
-470
-2% -$41.9K ﹤0.01% 2596
2023
Q4
$2.3M Buy
21,018
+4,804
+30% +$497K ﹤0.01% 2122
2023
Q3
$1.64M Sell
16,214
-15,998
-50% -$1.84M ﹤0.01% 2132
2023
Q2
$4.38M Buy
32,212
+16,116
+100% +$1.97M ﹤0.01% 1578
2023
Q1
$1.67M Sell
16,096
-4,129
-20% -$399K ﹤0.01% 2142
2022
Q4
$1.79M Buy
20,225
+3,700
+22% +$307K ﹤0.01% 2126
2022
Q3
$1.32M Sell
16,525
-12,887
-44% -$1.22M ﹤0.01% 2488
2022
Q2
$2.82M Buy
29,412
+1,101
+4% +$132K ﹤0.01% 1865
2022
Q1
$4.21M Buy
28,311
+2,704
+11% +$378K ﹤0.01% 1775
2021
Q4
$3.63M Buy
25,607
+7,098
+38% +$1.01M ﹤0.01% 2101
2021
Q3
$2.42M Sell
18,509
-3,323
-15% -$435K ﹤0.01% 2380
2021
Q2
$3M Sell
21,832
-13,474
-38% -$1.84M ﹤0.01% 2346
2021
Q1
$4.61M Buy
35,306
+20,733
+142% +$2.5M ﹤0.01% 1840
2020
Q4
$1.63M Buy
14,573
+3,247
+29% +$307K ﹤0.01% 3059
2020
Q3
$891K Sell
11,326
-16,654
-60% -$1.36M ﹤0.01% 3380
2020
Q2
$2.01M Buy
27,980
+6,953
+33% +$484K ﹤0.01% 2801
2020
Q1
$1.21M Sell
21,027
-6,986
-25% -$644K ﹤0.01% 2976
2019
Q4
$3.13M Sell
28,013
-8,812
-24% -$939K ﹤0.01% 2494
2019
Q3
$3.54M Buy
36,825
+14,484
+65% +$1.36M ﹤0.01% 2257
2019
Q2
$1.91M Buy
22,341
+16,003
+252% +$1.32M ﹤0.01% 2905
2019
Q1
$527K Sell
6,338
-17,419
-73% -$1.27M ﹤0.01% 4126
2018
Q4
$1.52M Sell
23,757
-2,375
-9% -$163K ﹤0.01% 2942
2018
Q3
$2.07M Buy
26,132
+11,536
+79% +$892K ﹤0.01% 2716
2018
Q2
$1.07M Buy
14,596
+14,122
+2,979% +$960K ﹤0.01% 3292
2018
Q1
$30K Sell
474
-89
-16% -$5.31K ﹤0.01% 6501
2017
Q4
$29K Buy
563
+161
+40% +$8.38K ﹤0.01% 6520
2017
Q3
$21K Buy
402
+221
+122% +$11.1K ﹤0.01% 6421
2017
Q2
$9K Sell
181
-197
-52% -$9.75K ﹤0.01% 6559
2017
Q1
$17K Sell
378
-39,450
-99% -$1.7M ﹤0.01% 6329
2016
Q4
$1.76M Buy
39,828
+18,268
+85% +$776K ﹤0.01% 3097
2016
Q3
$864K Buy
21,560
+9,503
+79% +$403K ﹤0.01% 3376
2016
Q2
$575K Sell
12,057
-7,993
-40% -$338K ﹤0.01% 3506
2016
Q1
$841K Buy
20,050
+19,648
+4,888% +$771K ﹤0.01% 3536
2015
Q4
$18K Buy
402
+398
+9,950% +$17.3K ﹤0.01% 6526
2015
Q3
$0 Sell
4
-638
-99% -$35K ﹤0.01% 7411
2015
Q2
$37K Sell
642
-1,115
-63% -$60.1K ﹤0.01% 5731
2015
Q1
$89K Buy
1,757
+888
+102% +$43.5K ﹤0.01% 5103
2014
Q4
$39K Sell
869
-463
-35% -$19.4K ﹤0.01% 5848
2014
Q3
$49K Buy
1,332
+684
+106% +$27.1K ﹤0.01% 5315
2014
Q2
$29K Sell
648
-4,946
-88% -$224K ﹤0.01% 5564
2014
Q1
$244K Sell
5,594
-18,877
-77% -$841K ﹤0.01% 4143
2013
Q4
$1.04M Buy
24,471
+5,104
+26% +$194K ﹤0.01% 3143
2013
Q3
$658K Sell
19,367
-6,808
-26% -$222K ﹤0.01% 3232
2013
Q2
$818K Buy
+26,175
New +$849K ﹤0.01% 3062

Other funds holding CNMD

Citigroup's CNMD Position: Q1 2026 in Review

Citigroup reduced its CONMED (CNMD) stake by 23% in Q1 2026, selling an estimated $99K and leaving 7,933 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #3835.

Citigroup first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.61M in Q1 2021. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Citigroup held 7,933 shares of CONMED worth $281K as of Q1 2026.
  • Citigroup sold 2,432 CONMED shares in Q1 2026, an estimated $99K.
  • CONMED made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3835 holding.
  • Citigroup first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's CONMED position peaked at $4.61M in Q1 2021.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.